COLUMBIA, Md., Aug. 28, 2017 -- W. R. Grace & Co. (NYSE:GRA) today announced that it has entered into a definitive agreement to acquire certain assets from Evonik Industries AG on September 5, 2017, following the close of Evonik’s acquisition of J.M. Huber Corporation’s silicas business. The assets to be acquired by Grace include trademarks and licenses to produce and sell Evonik’s SIDENT® dental precipitated silica product range and J.M. Huber Corporation’s defoamer and anti-caking product ranges, branded in the European Economic Area as Zeofoam™ and Zeoflo®, with worldwide product sales rights. Terms were not disclosed. The transaction will not change Grace’s 2017 outlook as of July 27, 2017.
“Grace has long been a leader in both the supply of dental silicas and the supply of additives to a variety of industries. The precipitated silica products and technologies will enable Grace to deliver more value to our leading global consumer products customers with some of the world’s most recognized toothpaste brands. The defoamer precursors and anti-caking agents are a great addition to our strong silica product portfolio,” said Sandra Wisniewski, President, Grace Materials Technologies. “These acquisitions reflect our commitment to our industrial and toothpaste customers and our strategy to grow our business through selective acquisitions.”
About Grace
Built on talent, technology, and trust, Grace is a leading global supplier of catalysts and engineered materials. The company’s two industry-leading business segments—Catalysts Technologies and Materials Technologies—provide innovative products, technologies, and services that enhance the products and processes of our customer partners around the world. With approximately 3,700 employees, Grace operates and/or sells to customers in over 60 countries. More information about Grace is available at grace.com.
Media Relations Rich Badmington T +1 410.531.4370 [email protected] Investor Relations Tania Almond T +1 410.531.4590 [email protected]


FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



